Sign in

brecht ingelbeen

@ingelbeen.bsky.social
706 followers 594 following 59 posts
PostsRepliesMedia
brecht ingelbeen @ingelbeen.bsky.social · 02/10/2026
net zoals in de rest van de wereld
000
Reposted by brecht ingelbeen
Ilan Schwartz @germhuntermd.bsky.social · 17/09/2026
Less is more, ortho-ID edition Another game changer in ortho ID from the group that brought you OVIVA Pts with ortho infections who underwent curative surgery (no DAIR) with local implantation of abx were randomized to <=7d vs >=4w ABx No Dif in 12 mo relapse www.nejm.org/doi/full/10.... #IDSky
Forest plot with primary analysis results which shows no difference in definite treatment failure, definite/probable treatment failure, or definite/probable/possible treatment failure according to treatment durationForest plot showing subgroup analysis which shows no difference between shorter and longer duration antibiotics in any of the subgroups including prosthetic infection, Staph aureus mono infection, and whether local gentamicin was used in mono therapy or combination therapy
23217
Reposted by brecht ingelbeen
The Lancet Microbe @lancetmicrobe.bsky.social · 06/08/2026
New research article Effects of a community-based intervention bundle on household transmission of [ESBL]-producing Escherichia coli in rural Burkina Faso to target community-level drivers of [ #AMR] in sub-Saharan Africa www.thelancet.com/journals/lan... #IDSky #ClinMicro #OpenAccess #OA
033
brecht ingelbeen @ingelbeen.bsky.social · 31/07/2026
it's not only the US govt that draws new borders for African countries unfortunately. newly drawn borders even seem to pass peer review: www.clinicalmicrobiologyandinfection.org/article/S119... (a short disclaimer in a footnote though)
clinicalmicrobiologyandinfection.org
Bundibugyo Ebolavirus outbreak in the Democratic Republic of the Congo and Uganda: rapid assessment from the European Society of Clinical Microbiology and Infectious Diseases Emerging Infections Subco...
The ongoing outbreak of Ebola virus disease (EVD) caused by Bundibugyo ebolavirus (BDBV) in the Democratic Republic of the Congo (DRC) and Uganda represents a major regional public health emergency wi...
120
Reposted by brecht ingelbeen
Sim Coddé @simcodde.bsky.social · 27/07/2026
Even reminder dat district Antwerpen binnenkort, in volle klimaatcrisis, heel deze linkse bomenrij kapt voor een extra parkeerstrook.
166329
Reposted by brecht ingelbeen
Ursula Hofer @hoferu.bsky.social · 18/06/2026
Bravo, stewardship in communities. Often ignored as it's difficult to tackle and research inevitably ends up somewhat messy. Nice podcast to go with the paper 👇
033
Reposted by brecht ingelbeen
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 17/06/2026
🔥Just published 🔥NEJM SNAP RCT In patients with MSSA bacteremia, cefazolin was noninferior to flucloxacillin or cloxacillin with respect to 90-day mortality and was associated with a lower incidence of acute kidney injury. #idsky www.nejm.org/doi/full/10....
nejm.org
Cefazolin for Methicillin-Susceptible Staphylococcus aureus Bacteremia | NEJM
Staphylococcus aureus bacteremia is associated with high mortality. Whether cefazolin or an antistaphylococcal penicillin should be preferred for the treatment of methicillin-susceptible S. aureus ...
03115
brecht ingelbeen @ingelbeen.bsky.social · 16/06/2026
More context on the choice of intervention, why so many intervention evaluation components, and such intervention's role in population-level AMR control: 🎧an accompanying podcast: open.spotify.com/episode/2Poz... 🌍an @itmantwerp.bsky.social website story: www.itg.be/en/health-st... #AMR #IDsky
itg.be
Improving antibiotic use in Burkina Faso & DRC
Helping to turn the tide on drug-resistant infections
031
brecht ingelbeen @ingelbeen.bsky.social · 16/06/2026
Community-based AMS interventions without biomarker tests can reduce antibiotic use by more than half - even more so for Watch antibiotics, with stable patient care scores. Results from CABU-EICO cluster RCT now published in @thelancetinfdis.bsky.social : authors.elsevier.com/a/1nHCg5E-Uo... #IDsky
121
brecht ingelbeen @ingelbeen.bsky.social · 01/06/2026
the map in it is totally inaccurate, which is even more shockingly given the history of european powers drawing up fictional borders there. please correct it
000
brecht ingelbeen @ingelbeen.bsky.social · 30/05/2026
If you still could, please correct that map. Anyone involved in response must have better maps than this catastrophic AI slur
000
brecht ingelbeen @ingelbeen.bsky.social · 27/04/2026
ik ken er niks van, en ben benieuwd wat voor issues je verwacht met een batterij die verkocht wordt als plug-in in het stopcontact? er is toch geen communicatie nodig met omvormer of digitale meter, dus waar zou het kunnen vastlopen?
110
brecht ingelbeen @ingelbeen.bsky.social · 14/01/2026
😂jammer wel van dat visgerecht
100
brecht ingelbeen @ingelbeen.bsky.social · 06/01/2026
Persisting barriers to health care access include: 1️⃣ Low acceptability, poor alignment between provider and population attitudes 2️⃣ Capacity + lack of integration of social & medical services 3️⃣ Geographical accessibility 4️⃣ Affordability and administrative barriers. @itmantwerp.bsky.social
030
brecht ingelbeen @ingelbeen.bsky.social · 06/01/2026
🔬ARTICLE: MORTALITY AND BARRIERS TO HEALTH CARE ACCESS IN HOMELESS PEOPLE IN PARIS Work by @evelinec.bsky.social ➡️ Median age of death 54 years, 26 years (!!) below general population ➡️ Most deaths due to cancer and cardiovascular diseases - like in the general pop link.springer.com/article/10.1...
link.springer.com
Mortality and barriers to healthcare among people experiencing homelessness in Paris: a mixed-methods study - International Journal for Equity in Health
International Journal for Equity in Health - Homelessness is a global problem with significant public health implications. Persons experiencing homelessness (PEH) face poorer health outcomes and...
101
Reposted by brecht ingelbeen
Doctors Without Borders / Médecins Sans Frontières (MSF) @msf.ca · 02/01/2026
Denying medical assistance is unacceptable in any circumstances. Israel’s threat to withhold registration from MSF & other INGOs is a cynical and calculated attempt to prevent organizations from providing services in #Gaza and the #WestBank, #Palestine. ow.ly/XQwE50XR5OE
7268175
Reposted by brecht ingelbeen
Esther van Kleef @esthervk.bsky.social · 20/12/2025
New PREPRINT! tinyurl.com/yynzevrh Thanks to a true transdisciplinary collaboration, we developed and evaluated a low-cost community #AMR intervention set in rural Burkina Faso and DRCongo. Combining #WHO #AWaRe–based feedback/training (medicine providers) and AMR awareness campaigns (community).
255
brecht ingelbeen @ingelbeen.bsky.social · 22/11/2025
For me, it's sobering to realize that another year passed while most primary care practices and hospitals around the world still lack a structural approach or resources to tackling #AMR. Luckily the relentless energy of those AMR advocates offers an annual boost of morale
020
brecht ingelbeen @ingelbeen.bsky.social · 22/11/2025
Every year during #WorldAntimicrobialAwarenessWeek I'm surprised by the diversity of media, approaches, and key messages used to reach and mobilize the public or healthcare workers, and to promote better antibiotic use—driven each time by the tireless and unparalleled energy of so many AMR advocates
130
brecht ingelbeen @ingelbeen.bsky.social · 18/11/2025
Nu het #WAAW is, schreef ik voor EOS een blog over ons onderzoek met CRUN in Burkina Faso. Waarom zijn er zoveel ernstige resistente bacteriële infecties op een plek waar antibioticagebruik niet excessief is? www.eoswetenschap.eu/gezondheid/w... #AMR @itmantwerp.bsky.social
eoswetenschap.eu
Waarom jaarlijks nog 200.000 kinderen sterven door antibioticaresistentie
In Europa treft antibioticaresistentie vooral ouderen en ziekenhuispatiënten, terwijl in lage-inkomenslanden vooral kinderen sterven aan infecties die resist...
011
brecht ingelbeen @ingelbeen.bsky.social · 03/11/2025
www.eoswetenschap.eu/gezondheid/w...
eoswetenschap.eu
Waarom jaarlijks nog 200.000 kinderen sterven door antibioticaresistentie
In Europa treft antibioticaresistentie vooral ouderen en ziekenhuispatiënten, terwijl in lage-inkomenslanden vooral kinderen sterven aan infecties die resist...
000
brecht ingelbeen @ingelbeen.bsky.social · 21/10/2025
😱😱 it's not just the abstract
000
brecht ingelbeen @ingelbeen.bsky.social · 21/10/2025
a global health journal gives you a limit of 200 words for the abstract of an article you've been working on for years so you decide to use these words to provide historical context 😬 #AMR
100
Reposted by brecht ingelbeen
Our World in Data @ourworldindata.org · 01/08/2025
Renewables have taken the lead in Dutch electricity production
The image presents a line graph illustrating the share of electricity generated from fossil fuels and renewables in the Netherlands from 1985 to 2024. 

The horizontal axis marks the years, starting at 1985 on the left and progressing to 2024 on the right. The vertical axis indicates the percentage of electricity generation, ranging from 0% to 100%. 

A brown line represents fossil fuels, which shows a gradual decline over the years, starting near 90% in 1985 and dropping sharply after 2015, approaching close to 40% by 2024. In contrast, a blue line illustrates renewables, showing a slow increase from nearly 0% in 1985 to a significant rise, crossing the fossil fuel line in 2024 to surpass it. 

The title notes the historic shift in Dutch electricity generation, indicating that for the first time, most electricity now comes from renewable sources. 

Data source: Ember (2025), Energy Institute (2024). The graph is licensed under CC BY.
922866
brecht ingelbeen @ingelbeen.bsky.social · 23/06/2025
Open position for an ID modeler @itmantwerp.bsky.social on community-level + healthcare transmission of resistant #AMR bacteria in LRS, working with Clinical Research Unit Nanoro, @esthervk.bsky.social, @bugwonk.bsky.social, KEMRI-wellcome Kilifi, myself,... #IDSky #EpiSky www.itg.be/en/jobs-and-...
itg.be
Epidemiologist
Epidemiologist for modelling AMR transmission in LMICMore than 500 staff members at the Institute of Tropical Medicine (ITM) contribute e...
064
brecht ingelbeen @ingelbeen.bsky.social · 06/05/2025
Thank you for sharing this. I don't get what @escmid.bsky.social hopes to obtain by restricting access after 6 months, or making it impossible to save posters
120
Reposted by brecht ingelbeen
stevenvangucht.bsky.social @stevenvangucht.bsky.social · 30/04/2025
Belgian waste water tells the story: Alpha. Delta. Omicron. Then viral loads dropped 10×. Not luck. Not just Omicron. But population immunity — built by vaccines + infections. Vaccines helped to avoid millions of deaths in the process. Graph: Raphael Janssens 🔗 www.linkedin.com/posts/vanguc...
021
brecht ingelbeen @ingelbeen.bsky.social · 30/04/2025
Great work at GLASS that @esthervk.bsky.social presented at #ESCMIDglobal, providing regional trends in AMR prevalence in bloodstream infections #AMR #IDSky
040
brecht ingelbeen @ingelbeen.bsky.social · 29/04/2025
GLASS report with 2022 AMU data is out #IDSky #AMR iris.who.int/bitstream/ha... It has per capita antibiotic use expressed in DDD per 1000 inhabitants per day, confirming DID is lower in most low-income than in most high-income countries Would be great to link population-wide AMU to AMR prevalence
021
Reposted by brecht ingelbeen
Christie Wilcox @nerdychristie.bsky.social · 24/04/2025
If you love strong, pour-over coffee, a team of physicists has a tip: Pour from as high as you can without causing the stream to break apart. That and more of the best in @science.org and science in this edition of #ScienceAdviser: www.science.org/content/arti... 🧪
06813
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
Vienna was marvelous and going from Copenhagen to ESCMID by day- and nightrain was a fantastic experience
040
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
I am surprised not to have picked up any major new treatment, prevention, or public health intervention breakthrough. I might have missed them, maybe I was queuing in the wrong lane, but blame the #ESCMIDGlobal app for that
120
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
8. A meeting organised by the ESCMID Study Group for Antimicrobial Stewardship actors involved in AMS in LMICs shared experiences. I retain that scaling of AMS beyond few tertiary care hospitals is nearly absent in LMIC, but still nowhere near in most HIC too. Let apart in primary care.
120
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
7. Two sessions on AMR and vaccines demonstrated again the lack of (recent) studies measuring effectiveness of (new+existing) vaccines on reducing antimicrobial use and AMR. Willian Hausdorff suggested developing combination vaccines by clinical presentation could better convince policy makers
110
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
6. Erika Vlieghe gave a talk on developing a sepsis national action plan in Belgium and had to start with a disclaimer on the complexity of healthcare decisionmaking, having to deal with 7 health ministers. Preventive and curative care are dealt with by different state levels.
110
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
5. Sonephet Vantava demonstrated how in hospitals in Lao PDR, healthcare worker attitudes and PPS antibiotic use data from will be combined to inform #AMS addressing frequent antibiotic use before and after delivery. Knowledge influences attitudes differently by profession @icarsglobal.bsky.social
101
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
Vilada Chansamouth then demonstrated how they used pathogen distribution and AMR prevalence data to develop guidelines in Lao PDR
110
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
4. A session on AMR surveillance gave excellent examples of analyzing and using clin micro AMR surveillance data, largely all examples from SE Asia. Many LMIC still struggle analyzing the data they have. Would be great if @WHO copy-pastes more from these examples
200
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
3. A session on biomarkers reviewed evidence on use of CRP to treat outpatient respi tract infections or fevers in low-resource settings. Large differences in effectiveness largely due to differences in antibiotic use prevalence. A cheap single malaria +semiquantitative CRP lateral flow test awaited
120
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
(I need to post one at a time apparently - takes a bit of time)
100
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
2. On relevant metrics to evaluate #AMS interventions: Days of Antibiotic Spectrum Coverage/DASC not only measures days of treatment but also at how wide the spectrum is of the antibiotic administered. Narrowing treatment is measured, and thus effectiveness in limiting selective pressure
131
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
1. Plans to harmonise and merge global-PPS and the WHO PPS. Countries I work with often pick the WHO PPS but then struggle to analyze antimicrobial use in sufficient detail to inform AMS or to benchmark w/ others. Planned for the next year or so, but still unclear how data sharing will go #ESCMID
100
brecht ingelbeen @ingelbeen.bsky.social · 15/04/2025
for 4,5 days of #ESCMIDGlobal with permanently 20 sessions in parallel and some #IDSky skeeters posting about sessions I wasn't in, more than once I had the feeling I have when picking a lane in a supermarket. Some bits I learned, mostly relevant for #AMR control intervention implementation in LMIC:
150
brecht ingelbeen @ingelbeen.bsky.social · 05/04/2025
Couldn’t it also have been a lower prevalence of known covid19 risk factors (diabetes, hypertension, copd) in each age stratum?
110
Reposted by brecht ingelbeen
Yanis Varoufakis @yanisvaroufakis.bsky.social · 31/03/2025
Day in day out, Israel is adding war crime to war crime, with the world looking for something 'new' to worry about. We are running the danger of becoming de-sensitised. Resistance now takes more than to condemn the genocide. We must also oppose the de-sensitisation of our souls!
11293108
Reposted by brecht ingelbeen
The Lancet Microbe @lancetmicrobe.bsky.social · 26/03/2025
New comment The cost of blood cultures: a barrier to diagnosis in low-income and middle-income countries www.thelancet.com/journals/lan... #IDSky #ClinMicro #OpenAccess #OA
034
Reposted by brecht ingelbeen
John Burn-Murdoch @jburnmurdoch.ft.com · 14/03/2025
NEW 🧵 Is human intelligence starting to decline? Recent results from major international tests show that the average person’s capacity to process information, use reasoning and solve novel problems has been falling since around the mid 2010s What should we make of this? www.ft.com/content/a801...
2892027813
Reposted by brecht ingelbeen
Infectious Diseases @infectiousdz.bsky.social · 13/03/2025
Cholera in Angola: As of 11 March 2025, a total of 6,651 cholera cases have been reported in Angola, with 240 death (Case Fatality Rate of 3.6%) The outbreak creates a risk for spread Despite no cholera in Namibia for over a decade, 1 case has been confirmed in Namibia, just south of Angola border
155
Reposted by brecht ingelbeen
Michael Wagner @michiwagner4.bsky.social · 12/03/2025
Before the introduction of measles vaccine in 1963 and widespread vaccination, major epidemics occurred approximately every two to three years and caused an estimated 2.6 million deaths each year www.who.int/news-room/fa...
who.int
Measles
Measles remains one of the leading causes of death among young children globally, despite the availability of a safe and effective vaccine.
43816
brecht ingelbeen @ingelbeen.bsky.social · 02/03/2025
Nee (wat het artikel ook concludeert) Is dit nu misinformation of disinformation @de-standaard.bsky.social?
010